...
首页> 外文期刊>Journal of Pure & Applied Microbiology >A Comparative Study on Pseudomonal and Bacillus L asparaginases
【24h】

A Comparative Study on Pseudomonal and Bacillus L asparaginases

机译:假炎和L芦冬酰胺酶的比较研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The enzyme L-asparaginase is commonly used in treatment of acute lymphoblastic leukemia (ALL). Due to its therapeutic importance and growing demands in medical and food industry much of the research have been focused to produce this enzyme with betteractivity and less disadvantages; for instance microbes have been extensively used to produce L asparaginase at affordable prices, a wide range of bacterial species have been reported that can produce high yields of this enzyme. The present study is an attempt to compare the production of L asparaginases between gram positive and gram negative bacterial species isolated from soil under same fermentation conditions. In this study the productions of L asparaginase from three species of Bacillus namely Bacillus subtilis (LC425423), Bacillus aerophilus (LC425427), Bacillus endophyticus (MG92850JJ and three strains of Pseudomonas aeruginosa (LC425424, LC425425, LC425426) was compared. The enzyme activity of L asparaginases produced from Bacillus species were noted as 8.5,14.3, 7.1 (U/ml). Whereas, the enzyme activity of L asparaginase produced from Pseudomonas aeruginosa strains (LC425424, LC425425, LC425426) was noted as, 8.2,19.4,19.1(U/ ml) respectively. In this study it was found that Pseudomonas aeruginosa strains yields was more in terms of protein concentration and enzyme activity when compared to Bacillus species. In addition this study also reports the use of modified Brain heart infusion media for screening and isolation of L asparaginase producing bacterial species. It was found that the number of colonies producing L asparaginase in modified Brain heart infusion media was comparatively same when compared to modified M9 media which is extensively used in screening of L asparaginase producers.A total of 159 L asparaginase producers were screened by using two fold dilution technique on modified BHI media while modified M9 media screened 163 colonies producing L asparaginase.
机译:酶L-天冬酰胺酶通常用于治疗急性淋巴细胞白血病(全部)。由于其治疗和食品行业的治疗性重要性和日益增长的要求,大部分研究都集中于生产这种酶,以更好地和更少的缺点;例如,微生物以经济实惠的价格广泛用于生产秋天酶,据报道,各种细菌种类可产生高产酶。本研究表明,试图比较从相同发酵条件下与土壤中分离的革兰氏阳性和革兰氏阴性细菌物种之间的L芦酰杀酶的产生。在这项研究中,比较了来自三种芽孢杆菌(LC425423),芽孢杆菌(LC425427),芽孢杆菌(LC425423),芽孢杆菌(LC425427),芽孢杆菌(Mg92850Jj和3株铜绿假单胞菌菌株(LC425424,LC425426)。酶活性L从芽孢杆菌物种产生的芦酰杀酶被注意为8.5,14.3,7.1(U / ml)。而来自假单胞菌铜绿假单胞菌菌株(LC425424,LC425,LC425426)产生的L天冬酰胺酶的酶活性(LC425424,LC425426),为8.2,19.4,19.1( u / ml)分别。在本研究中发现,与芽孢杆菌相比,铜绿假单胞菌菌株的产量更高,蛋白质浓度和酶活性更高。此外,本研究还报告使用改性的脑心脏输液介质进行筛选使用分离L芦氨酸酶产生细菌种类。发现改性脑心脏输注培养基中的L上氨酰蛋白酶的菌落数相对阶段E与经修饰的M9培养基相比,该M9培养基在筛选L天冬酰胺酶生产商中。通过在改性的BHI介质上使用两倍折叠稀释技术筛选总共159μl天冬酰胺酶生产商,同时改性M9培养基筛选的163种菌落产生L天冬氨酸酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号